Most of us would probably think of smoking or air pollution when it comes to lung cancer risk, but researchers have ...

The team from Cancer Research UK's Manchester Institute says it has created a new in vitro model of lung squamous cell ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Cancer Research scientists have developed a new cell-based model of lung squamous cell carcinoma (LUSC), a type of lung cancer, which has the potential to develop more effective treatments for the ...

New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

Laryngeal cancer affects the larynx (voice box) and often can be curable. Here are the treatment and surgical options and how ...

Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

An independent data monitoring board found that BeiGene’s ociperlimab was unlikely to significantly boost overall survival in ...

Chronic obstructive pulmonary disease (COPD) is a major cause of death among patients with renal cell carcinoma (RCC) in the United States, investigators reported at ASCO’s 2025 Genitourinary Cancers ...

EU approves AstraZeneca’s Imfinzi-in combo with chemotherapy to treat patients with resectable non-small cell lung cancer ...